Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study

Clinical Gastroenterology and Hepatology

Volumn 17, Issue 7, 2019, Pages 1323-1331.e6

  Murphy, Neil ^a   Ward, Heather A ^b   Jenab, Mazda ^a   Rothwell, Joseph A ^a   Boutron Ruault, Marie Christine ^c,d   Carbonnel, Franck ^c,d,e   Kvaskoff, Marina ^c,d   Kaaks, Rudolf ^f   Kühn, Tilman ^f   Boeing, Heiner ^g   Aleksandrova, Krasimira ^h   Weiderpass, Elisabete ^i,j,k,l   Skeie, Guri ^l   Borch, Kristin Benjaminsen ^l   Tjønneland, Anne ^m   Kyrø, Cecilie ^m   Overvad, Kim ⁿ   Dahm, Christina C ⁿ   Jakszyn, Paula ^o,p   Sánchez, Maria Jose ^q,r   Gil, Leire ^s   Huerta, José M ^r,t   Barricarte, Aurelio ^r,u,v   Quirós, J Ramón ^w   Khaw, Kay Tee ^x   Wareham, Nick ^x   Bradbury, Kathryn E ^y   Trichopoulou, Antonia ^z,aa   La Vecchia, Carlo ^z,ab   Karakatsani, Anna ^z,ac   Palli, Domenico ^ad   Grioni, Sara ^ae   Tumino, Rosario ^af   Fasanelli, Francesca ^ag   Panico, Salvatore ^ah   Bueno de Mesquita, Bas ^b,ai,aj,ak   Peeters, Petra H ^aj   Gylling, Björn ^al   Myte, Robin ^al   Jirström, Karin ^am   Berntsson, Jonna ^am   Xue, Xiaonan ^an   Riboli, Elio ^b   Cross, Amanda J ^b   Gunter, Marc J ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e BICÊTRE HOSPITAL   (France)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h Immunity and Metabolism Start up Lab   (Germany)

ⁱ CANCER REGISTRY OF NORWAY   (Norway)

^j KAROLINSKA INSTITUTE   (Sweden)

^k UNIVERSITY OF HELSINKI   (Finland)

^l UNIVERSITY OF TROMSØ   (Norway)

^m DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

ⁿ AARHUS UNIVERSITY   (Denmark)

^o CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^p UNIVERSITAT RAMON LLULL   (Spain)

^q UNIVERSITY OF GRANADA   (Spain)

^r CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^s BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^t DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^u INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^v IdiSNA Navarra Institute for Health Research   (Spain)

^w Public Health Directorate   (Spain)

^x UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^y UNIVERSITY OF OXFORD   (United Kingdom)

^z HELLENIC HEALTH FOUNDATION   (Greece)

^aa UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^ab UNIVERSITY OF MILAN   (Italy)

^ac UNIVERSITY OF ATHENS   (Greece)

^ad CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^ae NATIONAL CANCER INSTITUTE   (Italy)

^af Cancer Registry and Histopathology Unit   (Italy)

^ag UNIVERSITY OF TURIN   (Italy)

^ah UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ai NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^aj UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ak UNIVERSITY OF MALAYA   (Malaysia)

^al UMEÅ UNIVERSITY   (Sweden)

^am LUND UNIVERSITY   (Sweden)

^an ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Anatomic Subsite; Colorectal Cancer; Distal Colon; Heterogeneity; Proximal Colon; Rectum; Risk Factors

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALCOHOL CONSUMPTION; ANATOMIC LANDMARK; ANTHROPOMETRY; ARTICLE; ASCENDING COLON; BODY MASS; CANCER INCIDENCE; CANCER RISK; CECUM; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; EUROPE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; MIDDLE AGED; PHYSICAL ACTIVITY; PREVALENCE; RECTUM; RECTUM CANCER; SEX DIFFERENCE; SMOKING; TUMOR LOCALIZATION; TUMOR VOLUME; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADVERSE EVENT; CLINICAL TRIAL; COLON; COLONOSCOPY; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; DRINKING BEHAVIOR; EXERCISE; INCIDENCE; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; ALCOHOL DRINKING; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; EUROPE; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECTUM; RISK FACTORS; SMOKING;

EID: 85065866885     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2018.07.030     Document Type: Article

References (38)

1. Bray, F., Ferlay, J., Soerjomataram, I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68 (2018), 394–424.
2. Kocarnik, J.M., Shiovitz, S., Phipps, A.I., Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep 3 (2015), 269–276.
3. Wong, R., Proximal tumors are associated with greater mortality in colon cancer. J Gen Intern Med 25 (2010), 1157–1163.
4. Phipps, A.I., Lindor, N.M., Jenkins, M.A., et al. Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry. Dis Colon Rectum 56 (2013), 937–944.
5. Carethers, J.M., One colon lumen but two organs. Gastroenterology 141 (2011), 411–412.
6. Siegel, R., DeSantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J Clin 64 (2014), 104–117.
7. Yamauchi, M., Morikawa, T., Kuchiba, A., et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61 (2012), 847–854.
8. Iacopetta, B., Are there two sides to colorectal cancer?. Int J Cancer 101 (2002), 403–408.
9. Russo, A., Bazan, V., Iacopetta, B., et al. The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23 (2005), 7518–7528.
10. Wei, E.K., Giovannucci, E., Wu, K., et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 108 (2004), 433–442.
11. Limsui, D., Vierkant, R.A., Tillmans, L.S., et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 102 (2010), 1012–1022.
12. Riboli, E., Kaaks, R., The EPIC project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 (1997), S6–S14.
13. Xue, X., Kim, M.Y., Gaudet, M.M., et al. A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies. Cancer Epidemiol Biomarkers Prev 22 (2013), 275–285.
14. Pischon, T., Lahmann, P.H., Boeing, H., et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98 (2006), 920–931.
15. Burón Pust, A., Alison, R., Blanks, R., et al. Heterogeneity of colorectal cancer risk by tumour characteristics: large prospective study of UK women. Int J Cancer 140 (2017), 1082–1090.
16. Shin, A., Joo, J., Bak, J., et al. Site-specific risk factors for colorectal cancer in a Korean population. PLoS One, 6, 2011, e23196.
17. Wei, E.K., Colditz, G.A., Giovannucci, E.L., et al. A comprehensive model of colorectal cancer by risk factor status and subsite using data from the Nurses’ Health Study. Am J Epidemiol 185 (2017), 224–237.
18. Boyle, T., Keegel, T., Bull, F., et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst 104 (2012), 1548–1561.
19. Moore, S.C., Lee, I.M., Weiderpass, E., et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med 176 (2016), 816–825.
20. Lee, I., Djoussé, L., Sesso, H.D., et al. Physical activity and weight gain prevention. JAMA 303 (2010), 1173–1179.
21. Larsson, S.C., Wolk, A., Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86 (2007), 556–565.
22. Helmerhorst, H.J.F., Wijndaele, K., Brage, S., et al. Objectively measured sedentary time may predict insulin resistance independent of moderate- and vigorous-intensity physical activity. Diabetes 58 (2009), 1776–1779.
23. Woods, J.A., Vieira, V.J., Keylock, K.T., Exercise, inflammation, and innate immunity. Neurol Clin 24 (2006), 585–599.
24. Szapary, P.O., Bloedon, L.T., Foster, G.D., Physical activity and its effects on lipids. Curr Cardiol Rep 5 (2003), 488–493.
25. Zhou, B., Shu, B., Yang, J., et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control 25 (2014), 1397–1405.
26. Tsilidis, K.K., Branchini, C., Guallar, E., et al. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123 (2008), 1133–1140.
27. Chen, L., Li, L., Wang, Y., et al. Circulating C-peptide level is a predictive factor for colorectal neoplasia: evidence from the meta-analysis of prospective studies. Cancer Causes Control 24 (2013), 1837–1847.
28. Yao, X., Tian, Z., Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies. Cancer Causes Control 26 (2015), 257–268.
29. Keimling, M., Renehan, A.G., Behrens, G., et al. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemiol Biomarkers Prev 22 (2013), 1383–1394.
30. Moghaddam, A.A., Woodward, M., Huxley, R., Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16 (2007), 2533–2547.
31. Green, J., Cairns, B.J., Casabonne, D., et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12 (2011), 785–794.
32. World Cancer Research Fund-American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer. Continuous Update Project. Available from: http://www.wcrf.org/sites/default/files/CUP%20Colorectal%20Report_2017_Digital.pdf, 2017 Accessed August 2, 2018.
33. Thrift, A.P., Gong, J., Peters, U., et al. Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol 44 (2015), 662–672.
34. Riboli, E., Kaaks, R., The EPIC project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 (1997), S6–S14.
35. Riboli, E., Hunt, K.J., Slimani, N., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5 (2002), 1113–1124.
36. InterAct Consortium Peters, T., Brage, S., et al. Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol 27 (2012), 15–25.
37. Schoenfeld, D., Partial residuals for the proportional hazards regression model. Biometrika 69 (1982), 239–241.
38. Xue, X., Kim, M.Y., Gaudet, M.M., et al. A comparison of the polytomous logistic regression and joint Cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies. Cancer Epidemiol Biomarkers Prev 22 (2013), 275–285.